Antimicrobial resistance (AMR) has been classified by the World Health Organization (WHO) as a global health emergency. The threat it poses is so significant that it could undo nearly a century of medical progress.  According to the WHO's estimation, in 2019, bacterial AMR directly caused 1.27 million deaths and was associated with nearly 5 million deaths. What's more alarming is that a study in The Lancet predicted that between 2025 and 2050, AMR will directly lead to more than 39 million deaths - three people will die every three minutes - and another 169 million deaths will be related to AMR. The economic losses caused by AMR are also astonishing: the World Bank estimates that by 2030, AMR may cause a global GDP loss of up to 3.4 trillion US dollars and push 24 million people into extreme poverty.  However, the pipeline for developin...

Recently, in accordance with the relevant provisions of the "Evaluation Measures for Technology-oriented Small and Medium-sized Enterprises", OsBio (Suzhou) Biotechnology Co., Ltd. has been recognized as a "Technology-oriented Small and Medium-sized Enterprise" based on its R&D accumulation and innovative practices in the field of green biotechnology.   01. What is a "Technology-oriented Small and Medium-sized Enterprise"? Technology-oriented small and medium-sized enterprises rely on scientific and technical personnel to conduct R&D activities, own independent intellectual property rights, and transform these into high-tech products or services, thereby achieving sustainable development.   02. Behind the honor lies the perseverance and dedication of the R&D team This recognition as a "technology-based small and medium-sized enterprise...

OsBio (Suzhou) Biotechnology Co., Ltd. with its outstanding scientific and technological innovation strength and potential, has been listed as a "Zhihui Partner". This is not only a high recognition of the strength of OsBio, but also an important milestone on its development path.   Company Profile OsBio (Suzhou) Biotechnology Co., Ltd. is a spin-off company from the University of Oxford, located in Suzhou Industrial Park. We are committed to providing biotechnology services for human and environmental health, including biologics, molecular diagnostics, and carbon sequestration. The company supports global public health and individual health management, while developing sustainable green biotechnology to promote harmonious coexistence between humans and the environment.   Government empowerment "Zhihui Partner" is an important component of the Tale...